Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nephros (NEPH) Net Margin (2016 - 2025)

Historic Net Margin for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to 7.07%.

  • Nephros' Net Margin rose 18700.0% to 7.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 8.46%, marking a year-over-year increase of 153700.0%. This contributed to the annual value of 0.52% for FY2024, which is 115800.0% up from last year.
  • Per Nephros' latest filing, its Net Margin stood at 7.07% for Q3 2025, which was up 18700.0% from 5.36% recorded in Q2 2025.
  • In the past 5 years, Nephros' Net Margin registered a high of 11.87% during Q1 2025, and its lowest value of 134.12% during Q3 2022.
  • Its 5-year average for Net Margin is 25.73%, with a median of 12.21% in 2023.
  • Its Net Margin has fluctuated over the past 5 years, first plummeted by -867200bps in 2022, then skyrocketed by 1292600bps in 2023.
  • Quarter analysis of 5 years shows Nephros' Net Margin stood at 40.66% in 2021, then grew by 12bps to 35.89% in 2022, then soared by 44bps to 20.1% in 2023, then surged by 147bps to 9.41% in 2024, then decreased by -25bps to 7.07% in 2025.
  • Its last three reported values are 7.07% in Q3 2025, 5.36% for Q2 2025, and 11.87% during Q1 2025.